Chris Fegan

Heath Park
Cardiff, WLS, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory Tract.

Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory Tract.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 22, 2021

Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL.

Increased frequency of CD4+ PD-1+ HLA-DR+ T cells is associated with disease progression in CLL.

Journal: British journal of haematology

Published: August 08, 2019

Is venetoclax a new wonder drug in CLL?

Is venetoclax a new wonder drug in CLL?

Journal: British journal of haematology

Published: March 13, 2019

Telomere fusions associate with coding sequence and copy number alterations in CLL.

Telomere fusions associate with coding sequence and copy number alterations in CLL.

Journal: Leukemia

Published: September 06, 2018

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Journal: Blood cancer journal

Published: August 26, 2018

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.

Journal: British journal of haematology

Published: June 24, 2017

Telomere length is an independent prognostic marker in MDS but not in de novo AML.

Telomere length is an independent prognostic marker in MDS but not in de novo AML.

Journal: British journal of haematology

Published: November 12, 2016

Telomere length is a critical determinant for survival in multiple myeloma.

Telomere length is a critical determinant for survival in multiple myeloma.

Journal: British journal of haematology

Published: October 28, 2016

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Journal: Scientific reports

Published: October 05, 2016

Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptor.

Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptor.

Journal: Oncotarget

Published: July 06, 2016

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.

Journal: Nature communications

Published: July 04, 2016

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.

Journal: Blood

Published: January 20, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026